Markets We Serve
Our Platform Was Designed for Multiple Audiences
Whether you are saving the lives of patients, running clinical trials to test and bring great new cancer therapeutics to market, in the lab developing new magic bullets for cancer, or working on cancer informatics or new molecular diagnostics, the MatchTx solution is your new best tool in your toolbox. It was built on our proprietary algorithms that use our Deep Genetic Signatures™ (and other biomarkers) but is not black box – you get the full report of biomarker combinations that drive the matches, as well as the patient/sample cohorts and the outcome data.
For Your Patients
Predict how well the patient will respond to a drug, or which treatment is best, based on characteristics and outcomes of the best matched cohorts.
Use early trials data and outcomes to screen out (to other trials) patients predicted to have poor outcomes in your clinical trials, and adapt trials dynamically to get drugs to market faster.
Match new or re-positioned oncology drugs to genetically targeted populations to reduce costs and streamline development, screening, and clinical trials.
Utilize our Deep Genetic Signatures™ to match drug responses and clinical features/outcomes to new sets of genetic mutations or any other molecular diagnostics data.
What they say
When I saw the blinded prediction results after analyzing out first large clinical data set, I was truly amazed. Then when that model was just as accurate at predicting survival for the same cancer type of a completely different data set, I was astounded.
The MatchTx method enables finding the patient matches first, with no prior data assumptions or integration issues,and then interpreting the clinical and ‘Omics’ features associated with the outcomes later.
311 Kendall PL
Columbus, OH 43205
Please email us to arrange a call or web meeting